Senior Care Pharmacy Coalition Comments on Healthcare Choice and Competition
January 25, 2018
Via Electronic Submission: CompetitionRFI@hhs.gov
John R. Graham
Acting Assistant Secretary for Planning and Evaluation
Department of Health and Human Services
200 Independence Avenue, S.W.
Washington, D.C. 20201
Re: Response to RFI: Promoting Healthcare Choice and Competition
Dear Mr. Graham:
The Senior Care Pharmacy Coalition (SCPC) commends the office of the Assistant Secretary for Planning and Evaluation (ASPE) at the Department of Health and Human Services (HHS) for its request for information to promote healthcare choice and competition across the United States. We appreciate ASPE’s interest in input from the public on the extent to which existing State and Federal laws, regulations, guidance, requirements and policies limit choice and competition across all healthcare markets, and the identification of actions that States or the Federal Government could take to support the development and operation of a healthcare system that provides high‐quality care at affordable prices for the American people.
As the only organization in Washington that exclusively represents the interests of long-term care (LTC) pharmacies, the Senior Care Pharmacy Coalition (SCPC) has studied this issue closely and has several recommendations for ASPE’s consideration related to the distribution of prescription drugs across the country, and particularly the anticompetitive role that Pharmacy Benefit Managers (PBMs) play in that process.
ASPE also seeks information concerning laws, regulations and policies that, if modified, would enhance the ability of health care providers to provide the highest quality of care possible at an affordable and competitive price. In particular, modifying HHS policies regarding False Claims Act cases so they are consistent with recent Department of Justice policies would benefit competition, while reducing costs for both health care providers and the federal government.
Click here to read the submitted comments in their entirety.
Recent Posts
-
Experts fear damage to long-term care pharmacies as CMS touts newly negotiated drug prices
Even as the federal government on Thursday touted the billions of dollars in savings seniors can expect to see from newly negotiated, lower drug costs, pharmacies that supply long-term care facilities are warning of dire consequences.
-
Senior Care Pharmacy Coalition & “Save Senior Rx Care” Release Statement on Biden Administration’s Medicare Drug Pricing Announcement
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, and the new Save Senior Rx Care campaign released a statement today in response to the new drug pricing announcement: “Today, the Biden Administration released the negotiated 2026 prices for the ten most expensive Medicare Part D drugs, as […]
-
LTC pharmacies demand ‘sustainable’ payment model ahead of 2026 drug-pricing changes
Many of the nation’s long-term care pharmacies are going to fall below “break-even” and may be forced out of business without additional support when drug-pricing policy changes kick in, sector advocates warned Wednesday.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.